CN Patent

CN1311198A — 一种新的多肽——网格蛋白轻链37和编码这种多肽的多核苷酸

Assigned to Shanghai Biowindow Gene Development Inc · Expires 2001-09-05 · 25y expired

What this patent protects

本发明公开了一种新的多肽——网格蛋白轻链37,编码此多肽的多核苷酸和经DNA重组技术产生这种多肽的方法。本发明还公开了此多肽用于治疗多种疾病的方法,如恶性肿瘤,血液病,HIV感染和免疫性疾病和各类炎症等。本发明还公开了抗此多肽的拮抗剂及其治疗作用。本发明还公开了编码这种新的网格蛋白轻链37的多核苷酸的用途。

USPTO Abstract

本发明公开了一种新的多肽——网格蛋白轻链37,编码此多肽的多核苷酸和经DNA重组技术产生这种多肽的方法。本发明还公开了此多肽用于治疗多种疾病的方法,如恶性肿瘤,血液病,HIV感染和免疫性疾病和各类炎症等。本发明还公开了抗此多肽的拮抗剂及其治疗作用。本发明还公开了编码这种新的网格蛋白轻链37的多核苷酸的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN1311198A
Jurisdiction
CN
Classification
—
Expires
2001-09-05
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Biowindow Gene Development Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.